GSK acquires exclusive rights from Syndivia for antibody drug conjugate in prostate cancer Ruchika Sharma28 Oct 2025 10:30 AM ISTLondon: GSK plc and Syndivia, a private biotechnology company focused on next-generation ADCs, have announced an agreement granting GSK exclusive...
Drug combo cuts risk of death in advanced prostate cancer by 40%: NEJM Dr. Kamal Kant Kohli27 Oct 2025 10:00 PM ISTMen whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the...
Medical Bulletin 17/October/2025 Anshika Mishra17 Oct 2025 3:00 PM ISTHere are the top medical news for the day:Is Social Isolation an Overlooked Risk Factor in Cancer Mortality? People with cancer who experience...
JnJ gets USFDA priority review for Akeega plus prednisone for prostate cancer Ruchika Sharma17 Oct 2025 11:43 AM ISTHorsham: Johnson and Johnson has announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the company for its...
New Imaging Technique Detects Prostate Cancer Recurrence with 70 Percent Accuracy: Study Finds Anshika Mishra17 Oct 2025 8:15 AM ISTA new Canadian study has shown that a novel imaging technique, prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scanning,...
ASTRO: New therapy delays progression of recurrent prostate cancer Dr. Kamal Kant Kohli14 Oct 2025 9:00 PM ISTPatients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic body radiotherapy (SBRT)...
New drug combination offers hope for men with advanced prostate cancer: Study Dr. Kamal Kant Kohli13 Oct 2025 8:15 PM ISTA new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations,...
First-of-its-kind genomic test predicts benefit from hormone therapy added to radiation for recurrent prostate cancer: Study Dr. Kamal Kant Kohli1 Oct 2025 8:15 AM ISTA new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from...
Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva Ruchika Sharma23 Sept 2025 11:24 AM ISTHyderabad: Dr Reddy's Laboratories Ltd., has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use...
New tracer could enable surgeons to see and hear prostate cancer: Study Dr. Kamal Kant Kohli19 Sept 2025 11:00 PM ISTA preclinical evaluation of a new 'dual-mode' tracer agent shows promise in not only helping surgeons image and plan prostate cancer procedures, but...
Biocon Biologics wins USFDA nod for Bosaya and Aukelso, Denosumab Biosimilars Ruchika Sharma17 Sept 2025 5:36 PM ISTBengaluru: Biocon Biologics Ltd., a fully integrated global biosimilars company and subsidiary of Biocon Ltd., has announced that the U.S. Food...
Biparametric MRI Effective as Multiparametric MRI in Detecting Prostate Cancer: Study Jacinthlyn Sylvia14 Sept 2025 9:00 PM ISTA recent study published in the Journal of the American Medical Association found biparametric MRI to performs just as well as the current...
